765 results on '"O'Horo, John C."'
Search Results
2. COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
3. Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
4. Case-control study on post-COVID-19 conditions reveals severe acute infection and chronic pulmonary disease as potential risk factors
5. Variation in Sedative and Analgesic Use During the COVID-19 Pandemic and Associated Outcomes
6. A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19
7. Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States The Severe ARDS: Generating Evidence Study
8. Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experience
9. Augmented Curation of Unstructured Clinical Notes from a Massive EHR System Reveals Specific Phenotypic Signature of Impending COVID-19 Diagnosis
10. Imported Haycocknema perplexum Infection, United States
11. Supportive Care Management Recommendations for Mucocutaneous Manifestations of Monkeypox Infection
12. Variation in Sedative and Analgesic Use During the COVID-19 Pandemic and Associated Outcomes
13. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study
14. Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019
15. Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 Reinfection
16. Resolution of acute pulmonary embolism using anticoagulation therapy alone in coronavirus disease 2019
17. Diagnosis, management, and outcomes of brain abscess due to gram-negative versus gram-positive bacteria
18. Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection
19. Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records.
20. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022).
21. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020).
22. Contributors
23. Lower Respiratory Tract Infections
24. Ear, Nose, Throat, and Neck Infections
25. Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019–positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system
26. Echocardiographic Findings and Subsequent Risk of Native Valve Endocarditis
27. Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
28. Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
29. Bacterial Brain Abscess: An Outline for Diagnosis and Management
30. A Swollen Leg
31. Complicated Urinary Tract Infection With a Multidrug-Resistant Organism
32. Emergency Infectious Diseases
33. Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
34. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
35. Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance
36. Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19
37. Pre-existing conditions are associated with COVID-19 patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus
38. Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
39. Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019
40. Validation of a Retrospective Computing Model for Mortality Risk in the Intensive Care Unit
41. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
42. Sequential Time to Positivity as a Prognostic Indicator in Staphylococcus aureus Bacteremia.
43. Cefepime is Associated with Acute Encephalopathy in Critically Ill Patients: A Retrospective Case–Control Study
44. Mapping each pre-existing condition’s association to short-term and long-term COVID-19 complications
45. Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
46. Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
47. 1349. Unveiling the Link between COVID-19 and the Gut Microbiome in an Outpatient Cohort with Mild to Moderate Illness
48. 2432. Antibiotic Lock Therapy as a Line Salvage Strategy for Catheter-Related Bloodstream Infections: A Retrospective analysis
49. Understanding clinical implementation coordinators’ experiences in deploying evidence-based interventions
50. Genomic epidemiology reveals the dominance of Hennepin County in the transmission of SARS-CoV-2 in Minnesota from 2020 to 2022
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.